FDA Presses On to Phase Out Animal Testing as AI-Enabled Drug Discovery Picks Up Traction
In a significant departure for pharmaceutical and biotechnology companies, artificial intelligence (AI) is taking over a central role in drug discovery, in line with recent efforts by the U.S. Food and Drug Administration (FDA) to decrease animal testing. This overlap of technological innovation and regulatory reform has the potential to...
